ESC Premium Access

The cost-effectiveness of PCSK9 inihibitors in Australia

Topic: Lipids (Epidemiology and Prevention)

Congress Presentation

About the speaker

Doctor Ella Zomer

Monash University, Victoria (Australia)
0 follower

14 more presentations in this session

Open-label ODYSSEY APPRISE study: interim data from the first 843 participants

Speaker: Professor B. Cariou (Nantes, FR)


A one-year intervention combining weight loss and exercise increases the proportion of lipoprotein constituted by HDL and HDL particle size

Speaker: Doctor L. Pedersen (Copenhagen, DK)


Discordant low-density lipoprotein particle number versus low-density lipoprotein cholesterol is associated with increased C-reactive protein and poorer outcomes

Speaker: Doctor J. Meeusen (Rochester, US)


Coronary artery calcification is an independent predictor of cardiovascular events in familial hypercholesterolemia

Speaker: Associate Professor R. Santos (Sao Paulo, BR)


Substantial cardiovascular risks in heterozygous familial hypercholesterolemia patients with acute myocardial infraction who exhibited multi-vessel disease

Speaker: Doctor R. Nishikawa (Osaka, JP)


Access the full session

Poster session 2 - Lipids

Speakers: Doctor E. Zomer, Professor B. Cariou, Doctor L. Pedersen, Doctor J. Meeusen, Associate Professor R. Santos...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb